Preview Mode Links will not work in preview mode

This Week in Cardiology

Jun 16, 2023

AF screening, BNP, a new SGLT2 inhibitor, a sky-is-blue study, and the UK Mini Mitral surgical trial are discussed in this week's podcast

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I AF Screening

- Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study

- Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial

- Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders

- Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care

- Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design

- Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care

II Frailty and GDMT of HFrEF

Frailty Linked to Lower Use of Guideline Treatments in HFrEF

- Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction

III Sotagliflozin

FDA Approves New Drug, Sotagliflozin, for Heart Failure

- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

IV Mini-Mitral

Support for Minimally Invasive Mitral Valve Repair: Mini Mitral Published

- Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact: